Drugs by condition
Drugs approved for type 1 diabetes
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
39
Still marketed, NDA or BLA
Drug classes
8
Novel drugs
16
New molecular entities and new biologics
In development
12
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for type 1 diabetes.
- Onswik (Insulin Efsitora Alfa-Gobe) · Eli Lilly and CO NovelSep 23, 2026
- Zituvimet Xr (Metformin Hydrochloride, Sitagliptin) · Zydus Lifesciences Jul 18, 2024
- Zituvimet (Metformin Hydrochloride, Sitagliptin) · Zydus Lifesciences Nov 3, 2023
- Zituvio (Sitagliptin) · Zydus Lifesciences Oct 18, 2023
- Brenzavvy (Bexagliflozin) · Theracosbio NovelJan 20, 2023
All approved drugs for type 1 diabetes, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 75 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Sodium-Glucose Cotransporter 2 Inhibitor (6)
- Brenzavvy Bexagliflozin · Theracosbio · 2023
- Jardiance Empagliflozin · Boehringer Ingelheim · 2014
- Trijardy Xr Empagliflozin, Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2020
- Synjardy Xr Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
- Synjardy Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2015
- Glyxambi Empagliflozin, Linagliptin · Boehringer Ingelheim · 2015
Dipeptidyl Peptidase 4 Inhibitor (6)
- Tradjenta Linagliptin · Boehringer Ingelheim · 2011
- Zituvimet Xr Metformin Hydrochloride, Sitagliptin · Zydus Lifesciences · 2024
- Zituvimet Metformin Hydrochloride, Sitagliptin · Zydus Lifesciences · 2023
- Zituvio Sitagliptin · Zydus Lifesciences · 2023
- Jentadueto Xr Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
- Jentadueto Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2012
GLP-1 Receptor Agonist (2)
Sulfonylurea (2)
- Duetact Glimepiride, Pioglitazone Hydrochloride · Takeda Pharms USA · 2006
- Glucotrol Xl Glipizide · Pfizer · 1994
CD3-directed Antibody (1)
- Tzield Teplizumab-Mzwv · Provention Bio INC · 2022
Nonsteroidal Mineralocorticoid-Receptor Antagonist (1)
- Kerendia Finerenone · Bayer Hlthcare · 2021
Insulin Analog (1)
- Basaglar Insulin Glargine · Eli Lilly and CO · 2015
Class not listed in FDA's data (20)
- Onswik Insulin Efsitora Alfa-Gobe · Eli Lilly and CO · 2026
- Steglatro Ertugliflozin · Msd Sub Merck · 2017
- Ozempic Semaglutide · Novo · 2017
- Farxiga Dapagliflozin · Astrazeneca Ab · 2014
- Invokana Canagliflozin · Janssen Pharms · 2013
- Nesina Alogliptin Benzoate · Takeda Pharms USA · 2013
- Januvia Sitagliptin Phosphate · Msd · 2006
- Welchol Colesevelam Hydrochloride · Cosette · 2000
- Actos Pioglitazone Hydrochloride · Takeda Pharms USA · 1999
- Steglujan Ertugliflozin, Sitagliptin Phosphate · Msd Sub Merck · 2017
- Segluromet Ertugliflozin, Metformin Hydrochloride · Msd Sub Merck · 2017
- Invokamet Xr Canagliflozin, Metformin Hydrochloride · Janssen Pharms · 2016
- Xigduo Xr Dapagliflozin, Metformin Hydrochloride · Astrazeneca Ab · 2014
- Invokamet Canagliflozin, Metformin Hydrochloride · Janssen Pharms · 2014
- Kazano Alogliptin Benzoate, Metformin Hydrochloride · Takeda Pharms USA · 2013
- Oseni Alogliptin Benzoate, Pioglitazone Hydrochloride · Takeda Pharms USA · 2013
- Janumet Xr Metformin Hydrochloride, Sitagliptin Phosphate · Msd Sub Merck · 2012
- Cycloset Bromocriptine Mesylate · Veroscience · 2009
- Janumet Metformin Hydrochloride, Sitagliptin Phosphate · Msd Sub Merck · 2007
- Actoplus Met Metformin Hydrochloride, Pioglitazone Hydrochloride · Takeda Pharms USA · 2005
Drugs in development for type 1 diabetes
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- FrexalimabSAR441344Phase 39 trials
Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
- rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials
Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus
- THDB0206Phase 32 trials
Tonghua Dongbao Pharmaceutical Co.,Ltd · Type 2 Diabetes, Type 1 Diabetes
- TTP399CadisegliatinPhase 32 trials
vTv Therapeutics · Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1
- ZimislecelFormerly known as STx-02, VX-880Phase 32 trials
Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- BMF-219Phase 22 trials
Biomea Fusion Inc. · Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
- AcmopatideCT-868, RO7795074Phase 21 trial
Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus
- CNP-103Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM
- SAB-142Phase 21 trial
SAb Biotherapeutics, Inc. · Type 1 Diabetes
- VX-264Phase 21 trial
Vertex Pharmaceuticals · Type 1 Diabetes
- ZT-01Phase 21 trial
Zucara Therapeutics Inc. · Type 1 Diabetes Mellitus With Hypoglycemia
1 discontinued brand-name drugs whose label still names it
- Brynovin Sitagliptin Hydrochloride
More on type 1 diabetes: recruiting trials · published research
Related in cardiovascular and metabolic: Type 2 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High cholesterol · High triglycerides · Atrial fibrillation · Blood clots (DVT and pulmonary embolism) · Stroke prevention · Coronary artery disease and heart attack
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.